Galderma Group AG (SWX:GALD)
Switzerland · Delayed Price · Currency is CHF 149.30
+2.90 (1.98%)
Nov 6, 2025, 12:40 PM CET
Galderma Group AG Company Description
Galderma Group AG operates as a dermatology company worldwide.
The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology.
Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology.
The company was founded in 1981 and is headquartered in Zug, Switzerland.
Galderma Group AG
| Country | Switzerland |
| Founded | 1981 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,545 |
| CEO | Flemming Ornskov |
Contact Details
Address: Zählerweg 10 Zug, 6300 Switzerland | |
| Phone | 41 58 455 85 92 |
| Website | galderma.com |
Stock Details
| Ticker Symbol | GALD |
| Exchange | SIX Swiss Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | CH1335392721 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Flemming Ornskov M.B.A., M.D., M.P.H. | Chief Executive Officer and Director |
| Thomas J. W. Dittrich | Chief Financial Officer |
| Adrian Murphy | Head of Global Operations |
| Emil Ivanov | Head of Strategy, Investor Relations and ESG |
| Christian Marcoux | Chief Communications Officer |
| Allison Pinkham | Chief Human Resources Officer |